Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000711377-13-000036
Filing Date
2013-09-05
Accepted
2013-09-05 14:35:10
Documents
1
Period of Report
2013-09-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2755
  Complete submission text file 0000711377-13-000036.txt   4051
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address
Snyder Stephen K. (Reporting) CIK: 0001585837 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17988 | Film No.: 131080163